Powered by artificial intelligence, the new Ultrasound Workspace platform reportedly offers advanced echocardiography capabilities and facilitates enhanced diagnostic workflows.
In what may be a significant advance in echocardiography analysis and reporting across multiple systems, Philips launched the Ultrasound Workspace platform at the American College of Cardiology’s Annual Scientific Session and Expo (ACC 2022).
Combining 3D echocardiography capabilities with artificial intelligence (AI)-driven analysis and quantification tools, the Ultrasound Workspace also bolsters connectivity and reporting across different systems with vendor-neutral applications and remote browser access, according to Philips.
“We have combined the power of AI with deep clinical knowledge to create a solution that integrates into the workflows of healthcare providers to help drive efficient clinical decision-making,” noted Jeff Cohen, the senior vice president and global business leader of ultrasound for Philips. “With Ultrasound Workspace, our customers can experience a whole new world of echocardiography workflow to help improve both the patient and staff experience.”
Incorporating quality standards from the American Society of Echocardiography (ASE) and Intersocietal Accreditation Commission (IAC), Philips said the Ultrasound Workspace builds upon the capabilities of Philips’ ultrasound system EPIQ CV with improved efficiency and diagnostic confidence of quantitative measurements such as left ventricular ejection fraction.
Offering flexible licensing for facilities large and small, Philips noted that Ultrasound Workspace is a scalable platform that can be utilized as a stand-alone solution or incorporated into existing PACS and EMR echocardiography workflows.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.